UST, a global leader in digital transformation solutions, has entered into a strategic partnership with ThinkBio.Ai®, an AI-driven innovation company focused on the biopharmaceutical and healthcare sectors.

The collaboration aims to address key challenges in preclinical and clinical R&D by leveraging UST’s digital expertise and ThinkBio.Ai’s deep domain knowledge in oncology, immunology, neurology, and cardiology.

Focus areas include identifying optimal therapies, repurposing failed drugs, and improving clinical trial success through biomarker-led patient selection and digital twin-based trial matching.

A notable feature from ThinkBio.Ai is R-COP™ (Research Co-pilot), an AI-powered extension for Laboratory Information Management Systems (LIMS) that transforms routine workflows into dynamic, insight-rich operations. Insights are delivered through the BioThinkHub platform, a powerful data engine integrating curated proprietary and public datasets to generate actionable biological and clinical intelligence.